litlas
ログインアカウント作成

Chandra P. Belani

1994–2023 年に発表

85
論文数
23,141
被引用数
74
h 指数
85
i10 指数

被引用数

Chandra P. Belani の年別被引用数1948 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 3 件1997 年: 被引用 1 件1998 年: 被引用 4 件1999 年: 被引用 5 件2000 年: 被引用 12 件2001 年: 被引用 9 件2002 年: 被引用 27 件2003 年: 被引用 47 件2004 年: 被引用 126 件2005 年: 被引用 204 件2006 年: 被引用 192 件2007 年: 被引用 195 件2008 年: 被引用 205 件2009 年: 被引用 291 件2010 年: 被引用 270 件2011 年: 被引用 249 件2012 年: 被引用 208 件2013 年: 被引用 197 件2014 年: 被引用 172 件2015 年: 被引用 166 件2016 年: 被引用 162 件2017 年: 被引用 122 件2018 年: 被引用 131 件2019 年: 被引用 449 件2020 年: 被引用 511 件2021 年: 被引用 470 件2022 年: 被引用 379 件2023 年: 被引用 282 件2024 年: 被引用 356 件2025 年: 被引用 155 件2026 年: 被引用 6 件1949〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,246 件、この内訳の 26.9%中国: 引用元論文 920 件、この内訳の 11%イタリア: 引用元論文 465 件、この内訳の 5.6%イギリス: 引用元論文 427 件、この内訳の 5.1%日本: 引用元論文 413 件、この内訳の 4.9%ドイツ: 引用元論文 356 件、この内訳の 4.3%カナダ: 引用元論文 349 件、この内訳の 4.2%フランス: 引用元論文 348 件、この内訳の 4.2%スペイン: 引用元論文 264 件、この内訳の 3.2%オランダ: 引用元論文 222 件、この内訳の 2.6%韓国: 引用元論文 194 件、この内訳の 2.3%オーストラリア: 引用元論文 178 件、この内訳の 2.1%
0%26.9%その他 23.6%

機関

分野

  • Medicine69.7%
  • Biochemistry, Genetics and Molecular Biology23.7%
  • Immunology and Microbiology1.5%
  • Engineering0.8%
  • Materials Science0.8%
  • Physics and Astronomy0.6%
  • その他2.9%

トピック

  • Lung Cancer Treatments and Mutations12.7%
  • Lung Cancer Diagnosis and Treatment7.1%
  • Lung Cancer Research Studies6.3%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Cancer Genomics and Diagnostics3%
  • HER2/EGFR in Cancer Research2.2%
  • その他65%

共著者

全論文

検索で開く
  1. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer

    著者: Christian Rolfo, Philip C. Mack, Giorgio V. Scagliotti, Charu Aggarwal, Maria E. Arcila, Fabrice Barlési, Trever G. Bivona, Maximilian Diehn, Caroline Dive, Rafał Dziadziuszko, Natasha B. Leighl, Umberto Malapelle, Tony Mok, Nir Peled, Luis E. Raez, Lecia V. Sequist, Lynette M. Sholl, Charles Swanton, Chris Abbosh, Daniel S.W. Tan, Heather A. Wakelee, Ignacio I. Wistuba, Rebecca A. Bunn, Janet Freeman‐Daily, Murry W. Wynes, Chandra P. Belani, Tetsuya Mitsudomi, David R. Gandara - Journal of Thoracic Oncology 2021 被引用: 645

  2. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

    著者: Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar, Saroj Vadhan‐Raj, Hanno Riess, Ted Wun, Michael B. Streiff, David García, Howard A. Liebman, Chandra P. Belani, Eileen M. O’Reilly, Jai N. Patel, Habte Yimer, Peter Wildgoose, Paul Burton, Ujjwala Vijapurkar, Simrati Kaul, John W. Eikelboom, Robert D. McBane, Kenneth A. Bauer, Nicole M. Kuderer, Gary H. Lyman - New England Journal of Medicine 2019 被引用: 714

  3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

    著者: Joan H. Schiller, David Harrington, Chandra P. Belani, Corey J. Langer, Alan Sandler, James E. Krook, Junming Zhu, David H. Johnson - New England Journal of Medicine 2002 被引用: 4,984

  4. Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes

    著者: Yuan Wan, Gong Cheng, Xin Liu, Si-Jie Hao, Merisa Nisic, Chuan-Dong Zhu, Yi-Qiu Xia, Wen-Qing Li, Zhigang Wang, Wen-Long Zhang, Shawn J. Rice, Aswathy Sebastian, István Albert, Chandra P. Belani, Siyang Zheng - Nature Biomedical Engineering 2017 被引用: 275

  5. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

    著者: Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts, Tibor Csőszi, Gyula Ostoros, Z. Mark, Christina S. Baik, Anil A. Joy, C. Chouaïd, Jesus Corral Jaime, Vı́tězslav Kolek, Margarita Majem, Jaromı́r Roubec, Edgardo S. Santos, Anne C. Chiang, Giovanna Speranza, Chandra P. Belani, Alberto Chiappori, Manish R. Patel, Krisztina Czebe, Lauren A. Byers, Brittany Bahamón, Cong Li, Emily Sheldon‐Waniga, Eric Kong, Miguel Williams, Sunita Badola, Hyunjin Shin, Lisa Bedford, Jeffrey Ecsedy, Matthew Bryant, Siân Jones, John K. Simmons, E. Jane Leonard, Claudio Dansky Ullmann, David R. Spigel - Journal of Thoracic Oncology 2019 被引用: 147

  6. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer

    著者: Matthew P. Smeltzer, Murry W. Wynes, Sylvie Lantuéjoul, Ross A. Soo, Suresh S. Ramalingam, Marileila Varella‐Garcia, Meghan M. Taylor, K. Richeimer, K. Wood, Kristen E. Howell, Mercedes Lilana Dalurzo, Enriqueta Felip, G. Hollenbeck, Keith M. Kerr, Edward S. Kim, Clarissa Mathias, Jose M. Pacheco, Pieter E. Postmus, Charles S. Powell, Masahiro Tsuboi, Ignacio I. Wistuba, Heather A. Wakelee, Chandra P. Belani, Giorgio V. Scagliotti, Fred R. Hirsch - Journal of Thoracic Oncology 2020 被引用: 186

  7. Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

    著者: Rathi N. Pillai, Madhusmita Behera, Taofeek K. Owonikoko, Alice O. Kamphorst, Suchita Pakkala, Chandra P. Belani, Fadlo R. Khuri, Rafi Ahmed, Suresh S. Ramalingam - Cancer 2017 被引用: 324

  8. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

    著者: Gregory M.M. Videtic, Rebecca Paulus, Anurag K. Singh, Joe Y. Chang, William Parker, Kenneth R. Olivier, Robert Timmerman, Ritsuko Komaki, James J. Urbanic, Kevin L. Stephans, Sue S. Yom, Clifford G. Robinson, Chandra P. Belani, Puneeth Iyengar, Munther Ajlouni, Darindra Gopaul, Jorge B. Gomez Suescun, Ronald C. McGarry, Hak Choy, Jeffrey D. Bradley - International Journal of Radiation Oncology*Biology*Physics 2018 被引用: 291

  9. Vorinostat in solid and hematologic malignancies

    著者: David S. Siegel, Mohamad A. Hussein, Chandra P. Belani, Francisco Robert, Evanthia Galanis, Victoria M. Richon, J. Garcia‐Vargas, César Sanz-Rodrı́guez, Syed Rizvi - Journal of Hematology & Oncology 2009 被引用: 203

  10. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

    著者: Mark G. Kris, Ronald B. Natale, Roy S. Herbst, T. J. Lynch, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, H. Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael Wolf, Steven D. Averbuch, Judith Ochs, Andrea Kay - JAMA 2003 被引用: 2,538

  11. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

    著者: Sanja Đačić, William D. Travis, Mary W. Redman, Anjali Saqi, Wendy A. Cooper, Alain Borczuk, Jin-Haeng Chung, Carolyn Glass, Javier Martin Lopez, Anja C. Roden, Lynette M. Sholl, Annikka Weissferdt, Juan Posadas, Angela M. Walker, Hu Zhu, Manuja T. Wijeratne, Casey Connolly, Murry W. Wynes, Neus Bota‐Rabassedas, Beatriz Sánchez‐Espiridión, J.Jack Lee, Sabina Berezowska, Teh‐Ying Chou, Keith M. Kerr, Andrew G. Nicholson, Claudia Poleri, Kurt A. Schalper, Ming‐Sound Tsao, David P. Carbone, Neal Ready, Tina Cascone, John V. Heymach, Boris Sepesi, Catherine A. Shu, Naiyer A. Rizvi, Josuha Sonett, Nasser K. Altorki, Mariano Provencio, Paul A. Bunn, Mark G. Kris, Chandra P. Belani, Karen Kelly, Ignacio I. Wistuba - Journal of Thoracic Oncology 2023 被引用: 40

  12. Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database

    著者: Taofeek K. Owonikoko, Camille Ragin, Chandra P. Belani, Ana B. Oton, William E. Gooding, Emanuela Taioli, Suresh S. Ramalingam - Journal of Clinical Oncology 2007 被引用: 570

  13. Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells

    著者: Ramdane Harouaka, Ming-Da Zhou, Yin‐Ting Yeh, Waleed Khan, Avisnata Das, Xin Liu, Christine C Christ, David T. Dicker, Tara Baney, Jussuf T. Kaifi, Chandra P. Belani, Cristina I. Truica, Wafik S. El‐Deiry, Jeffrey P. Allerton, Si-Yang Zheng - Clinical Chemistry 2013 被引用: 142

  14. Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

    著者: Audrey Mauguen, Jean‐Pierre Pignon, Sarah Burdett, Caroline Domerg, David J. Fisher, Rebecca Paulus, Samithra J Mandrekar, Chandra P. Belani, Frances A. Shepherd, Tim Eisen, Herbert Pang, Laurence Collette, William T. Sause, Suzanne E. Dahlberg, Jeffrey Crawford, Mary O’Brien, Steven E. Schild, Mahesh Parmar, Jayne F. Tierney, C. Le Péchoux, Stefan Michiels - The Lancet Oncology 2013 被引用: 245

  15. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

    著者: Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh, Michael Tanaka, Heinz‐Josef Lenz, Yun Yen, Hedy L. Kindler, Syma Iqbal, Jeff Longmate, Philip C. Mack, Georg Lurje, Regina Gandour‐Edwards, Janet Dancey, David R. Gandara - Cancer Chemotherapy and Pharmacology 2009 被引用: 287

  16. The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative

    著者: Stephen Lam, Murry W. Wynes, Casey Connolly, Kazuto Ashizawa, Sukhinder Atkar-Khattra, Chandra P. Belani, Domenic DiNatale, Claudia I. Henschke, Bruno Hochhegger, Claudio Jacomelli, Małgorzata Jelitto, Artit Jirapatnakul, Karen Kelly, Karthik Krishnan, Takeshi Kobayashi, Jacqueline Logan, Juliane Nascimento de Mattos, John R. Mayo, Annette McWilliams, Tetsuya Mitsudomi, Ugo Pastorino, Joanna Polańska, Witold Rzyman, Ricardo Sales dos Santos, Giorgio V. Scagliotti, Heather A. Wakelee, David F. Yankelevitz, John K. Field, James L. Mulshine, Ricardo S. Avila - Journal of Thoracic Oncology 2023 被引用: 19

  17. Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

    著者: Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Athanassios Argiris, Marianna Koczywas, Barbara J. Gitlitz, Sachdev Thomas, Igor Espinoza‐Delgado, Everett E. Vokes, David R. Gandara, Chandra P. Belani - Journal of Clinical Oncology 2009 被引用: 270

  18. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

    著者: Tudor–Eliade Ciuleanu, Thomas Brodowicz, Christoph Zielinski, Joo Hang Kim, Maciej Krzakowski, Eckart Laack, Yi‐Long Wu, Isabel Bover, Stephen Begbie, Valentina Tzekova, Branka Čučević, José Rodrigues Pereira, Sung Hyun Yang, Jayaprakash Madhavan, Katherine P. Sugarman, Patrick Peterson, William J. John, Kurt Krejcy, Chandra P. Belani - The Lancet 2009 被引用: 1,118

  19. Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

    著者: Suresh S. Ramalingam, Robert A. Parise, Ramesh K. Ramananthan, Theodore Lagattuta, Lori A. Musguire, Ronald G. Stoller, Douglas M. Potter, Athanassios Argiris, James A. Zwiebel, Merrill J. Egorin, Chandra P. Belani - Clinical Cancer Research 2007 被引用: 196

  20. A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors

    著者: Ramesh K. Ramanathan, D. Lynn Kirkpatrick, Chandra P. Belani, David Friedland, Sylvan B. Green, H.‐H. Sherry Chow, Catherine A. Cordova, Steven P. Stratton, Elizabeth R. Sharlow, Amanda F. Baker, Tomislav Dragovich - Clinical Cancer Research 2007 被引用: 105

  21. Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer

    著者: Benjamin Besse, L. Claire Tsao, Debra T. Chao, Ying Fang, Jean‐Charles Soria, Salah Almokadem, Chandra P. Belani - Annals of Oncology 2012 被引用: 79

  22. Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)

    著者: Karen L. Reckamp, Paul Frankel, Nora Ruel, Philip C. Mack, Barbara J. Gitlitz, Tianhong Li, Marianna Koczywas, Shirish M. Gadgeel, Mihaela Cristea, Chandra P. Belani, Edward M. Newman, David R. Gandara, Primo N. Lara - Frontiers in Oncology 2019 被引用: 45

  23. Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

    著者: Frank V. Fossella, Jose R. Pereira, Joachim von Pawel, A Płużańska, Vera Gorbounova, E. Kaukel, K. Mattson, Rodryg Ramlau, Aleksandra Szczęsna, P. Fidias, Michael Millward, Chandra P. Belani - Journal of Clinical Oncology 2003 被引用: 943

  24. Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

    著者: Giorgio V. Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank V. Fossella, Katherine P. Sugarman, Chandra P. Belani - Journal of Thoracic Oncology 2010 被引用: 253